Paper34858740
Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes.
Kamolvisit S and 3 others. Cureus, 2021. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes. Papers, record 34858740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34858740
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30888594 | Pharmacological Treatment for Non-alcoholic Fatty Liver Disease. | Adv Ther | 2019 | https://conductscience.org/library/papers/30888594 | PubMed |
| 2 | 33069882 | Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus. | Clin Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/33069882 | PubMed |
| 3 | 22326434 | Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. | Gastroenterology | 2012 | https://conductscience.org/library/papers/22326434 | PubMed |
| 4 | 30683625 | Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. | Lancet HIV | 2019 | https://conductscience.org/library/papers/30683625 | PubMed |
| 5 | 30570529 | Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study. | J Acquir Immune Defic Syndr | 2019 | https://conductscience.org/library/papers/30570529 | PubMed |
| 6 | 11768834 | A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus. | Clin Ther | 2001 | https://conductscience.org/library/papers/11768834 | PubMed |
| 7 | 24673640 | Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time. | Diabet Med | 2014 | https://conductscience.org/library/papers/24673640 | PubMed |
| 8 | 30335697 | Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. | Transplantation | 2019 | https://conductscience.org/library/papers/30335697 | PubMed |
| 9 | 21618575 | Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. | Hepatology | 2011 | https://conductscience.org/library/papers/21618575 | PubMed |
| 10 | 22435761 | Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. | Liver Int | 2012 | https://conductscience.org/library/papers/22435761 | PubMed |
| 11 | 29223443 | Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes. | Clin Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/29223443 | PubMed |
| 12 | 15616246 | Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. | Diabetes Care | 2005 | https://conductscience.org/library/papers/15616246 | PubMed |
| 13 | 22879786 | Pioglitazone in the treatment of type 2 diabetes: safety and efficacy review. | Clin Med Insights Endocrinol Diabetes | 2010 | https://conductscience.org/library/papers/22879786 | PubMed |
| 14 | 27621571 | Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/27621571 | PubMed |
| 15 | 27322798 | Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial. | Ann Intern Med | 2016 | https://conductscience.org/library/papers/27322798 | PubMed |
| 16 | 29222911 | Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | Hepatology | 2018 | https://conductscience.org/library/papers/29222911 | PubMed |
| 17 | 17135584 | A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. | N Engl J Med | 2006 | https://conductscience.org/library/papers/17135584 | PubMed |
| 18 | 22760655 | Nonalcoholic fatty liver disease and HIV infection. | Semin Liver Dis | 2012 | https://conductscience.org/library/papers/22760655 | PubMed |
| 19 | 27485838 | Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV. | Curr HIV/AIDS Rep | 2016 | https://conductscience.org/library/papers/27485838 | PubMed |
| 20 | 28714183 | The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. | Hepatology | 2018 | https://conductscience.org/library/papers/28714183 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41799137 | Virtual Screening of FDA-Approved Compounds: Exploring New Alternatives for HIV Treatment. | ACS Omega | 2026 | https://conductscience.org/library/papers/41799137 | PubMed |
| 40860752 | MAFLD: A Comprehensive Review of the Link Between Metabolic Dysfunction and Cardiovascular Risk. | Hepat Med | 2025 | https://conductscience.org/library/papers/40860752 | PubMed |
| 40397552 | Metabolic dysfunction-associated steatotic liver disease in people with HIV. | Curr Opin HIV AIDS | 2025 | https://conductscience.org/library/papers/40397552 | PubMed |
| 39552706 | Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer. | Am J Prev Cardiol | 2024 | https://conductscience.org/library/papers/39552706 | PubMed |
| 37745748 | Efficacy of SGLT2 Inhibitors Versus Pioglitazone in the Treatment of Non-alcoholic Fatty Liver Disease or Non-alcoholic Steatohepatitis: A Systematic Review. | Cureus | 2023 | https://conductscience.org/library/papers/37745748 | PubMed |
| 37280241 | Metabolic dysfunction-associated fatty liver disease in people living with HIV. | Sci Rep | 2023 | https://conductscience.org/library/papers/37280241 | PubMed |
| 37111209 | Nutritional and Lifestyle Therapy for NAFLD in People with HIV. | Nutrients | 2023 | https://conductscience.org/library/papers/37111209 | PubMed |
| 37065735 | Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37065735 | PubMed |
| 36936142 | Effects of SGLT2 inhibitors on hepatic fibrosis and steatosis: A systematic review and meta-analysis. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/36936142 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| PPARG | 5468 | PubTator's text mining | https://conductscience.org/library/genes/5468 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34858740
GET https://conductscience.org/api/papers/v1/34858740/references?page=2